Manager, Market Intelligence and Strategy

About the role

This individual will lead and support many different aspects of competitive and market intelligence to support new product planning. Example workstreams include competitive monitoring and tracking, conference coverage, and strategy development. The ideal candidate will conduct primary and secondary research to gather market insights and data and use them to inform analysis and planning implications. This individual will be expected to lead the Competitive Intelligence workstream and distill market insights and data in a timely manner to create concise summaries for internal communications. They will also support various strategic workstreams by conducting focused evaluations of market trends and supporting commercial assessments to help drive recommendations.

Responsibilities

• Competitive Landscape
• Lead competitive intelligence activities, including tracking, analyzing, synthesizing, and communicating competitor and industry activity across key stakeholders (Strategy, Regulatory Affairs, Medical Affairs, Clinical Development, Clinical Operations, and Business Development).
• Monitor industry activity and emerging trends through conference coverage and external intelligence to inform internal decision-making.
• Market Insights
• Gather, analyze, and synthesize market data to support data-driven insights and timely communication to internal stakeholders.
• Design and execute cross-functional primary market research, partnering with internal teams to define objectives, methodologies, and select vendors (HCPs, KOLs, patients, payers, and advanced analytics partners).
• Translate market research, claims analysis, and payer insights into early go-to-market strategy and commercialization readiness.
• New Product Planning
• Monitor and routinely update competitor pipeline and strategic direction to inform forward-looking internal program strategy, positioning, and planning.
• Identify gaps and opportunities within the evolving landscape to support early commercial strategy development, including treatment positioning, segmentation, pricing scenarios, and foundational launch assumptions.
• Routinely present insights and strategic recommendations to senior leadership and cross-functional leadership teams to inform decision-making.
• Develop investor- and Board-facing slide decks that articulate competitive differentiation and strategic positioning.
• The Necessities
• At Entrada, our passion for science, our devotion to patients and our values drives our behavior:
• Humanity - We genuinely care about patients and about one another.
• Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients.
• Creativity - We are creativ

Additional Information

The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are interested in working at the intersection of life sciences and business. You want to join a high growth biotech company in a business strategy role to help support the team by synthesizing and communicating strategic insights from market and competitor developments. You bring to the table the combination of an inquisitive spirit, critical thinking, and analytical skills. You love following innovative science, performing data-driven analyses and contributing strategic insights. You thrive in figuring out the details and understanding the nuances while still making connections to the bigger picture. You look forward to working with and learning from cross-functional leaders across the organization while helping shape long-term strategy

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at entradatherapeutics? Share your experience